Discover more articles

# Viewpoints


The race for a vaccine against this virus, and the ones coming after

By Alice Park

2 min of reading

This article is from the issue  20200208

p.42 Published

When chinese researchers publicly posted the genetic sequence of the new coronavirus, scientists got busy. Nearly a dozen pharmaceutical companies launched programs to develop drugs or vaccines against the new virus, 2019-nCoV. Both are needed, but vaccines are preferable to drugs, since immunizing people against infections is the best way to prevent spread of the disease and protect entire populations. Members of the infectious-disease team at the U.S. National Institutes of Health (...
Loading ...

Your access to this extract has ended

To continue reading

Sign up now!

Sign up

Already a subscriber ?

You obviously appreciate quality information.


Press everywhere,
any time

Unlimited Articles

A catalogue of more
than 1800 titles

ENJOY A MONTH £ 0.99 Subscribe for £6,99/month

then £6,99/month .

In the same issue,

Other articles that might interest you

By continuing to browse this website, you accept the use of cookies and other tracking technologies by Cafeyn and its partners to offer content and offers tailored to your interests, personalised advertising and analyse our traffic.

Review settings and learn more